Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

AbbVie tries a new approach in 340B programme battle

 April 9, 2026

Pharmaphorum

AbbVie has opened a new front in the pharma industry’s efforts to reform the 340B drug discounting programme for safety net hospitals in the US.

Policy / PricingRead full story

Post navigation

The FTC Blows Up Express Scripts’ PBM Model–and Launches the Net Pricing Drug Channel (rerun) →
← Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com